63 related articles for article (PubMed ID: 33456115)
21. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
[TBL] [Abstract][Full Text] [Related]
22. The effect of age On cervical cancer screening in women aged 20-29.
Tuncer HA; Tuncer SF
Acta Clin Croat; 2020 Jun; 59(2):277-284. PubMed ID: 33456115
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
24. Risk for Cervical Intraepithelial Neoplasia Grade 3 or Higher in Follow-Up of Women With a Negative Cervical Biopsy.
Tverelv LR; Sørbye SW; Skjeldestad FE
J Low Genit Tract Dis; 2018 Jul; 22(3):201-206. PubMed ID: 29543686
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening.
Luo H; Belinson JL; Du H; Liu Z; Zhang L; Wang C; Qu X; Pretorius RG; Wu R
J Low Genit Tract Dis; 2017 Jan; 21(1):12-16. PubMed ID: 27851695
[TBL] [Abstract][Full Text] [Related]
27. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
28. TWENTY-YEAR EXPERIENCE WITH LARGE LOOP EXCISION OF THE TRANSFORMATION ZONE AT SESTRE MILOSRDNICE UNIVERSITY HOSPITAL CENTRE.
Butorac D; Škrtić B; Čukelj M; Kuna K; Djaković I
Acta Clin Croat; 2019 Sep; 58(3):463-466. PubMed ID: 31969758
[TBL] [Abstract][Full Text] [Related]
29. FACTORS ASSOCIATED WITH PERSISTENCE OF HPV GENITAL INFECTION IN A SMALL COHORT OF ROMANIAN WOMEN.
Huică I; Iancu IV; Botezatu A; Pleşa A; Socolov D; Teleman S; Anton G
Acta Clin Croat; 2019 Sep; 58(3):410-416. PubMed ID: 31969751
[TBL] [Abstract][Full Text] [Related]
30. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
31. Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis.
Bekos C; Schwameis R; Heinze G; Gärner M; Grimm C; Joura E; Horvat R; Polterauer S; Polterauer M
Sci Rep; 2018 Apr; 8(1):6383. PubMed ID: 29686397
[TBL] [Abstract][Full Text] [Related]
32. Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.
Averbach S; Silverberg MJ; Leyden W; Smith-McCune K; Raine-Bennett T; Sawaya GF
Contraception; 2018 Apr; ():. PubMed ID: 29673740
[TBL] [Abstract][Full Text] [Related]
33. Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women - A case-control study from Finland.
Makkonen P; Heinävaara S; Sarkeala T; Anttila A
Gynecol Oncol; 2017 Dec; 147(3):601-606. PubMed ID: 28942994
[TBL] [Abstract][Full Text] [Related]
34. Cervical Cancer Screening of Adolescents Should Not Be Encouraged.
Henrique LQ; Campaner AB; dʼAvila FS
J Low Genit Tract Dis; 2017 Jan; 21(1):21-25. PubMed ID: 28027120
[TBL] [Abstract][Full Text] [Related]
35. Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era.
Benard VB; Castle PE; Jenison SA; Hunt WC; Kim JJ; Cuzick J; Lee JH; Du R; Robertson M; Norville S; Wheeler CM;
JAMA Oncol; 2017 Jun; 3(6):833-837. PubMed ID: 27685805
[TBL] [Abstract][Full Text] [Related]
36. The Korean guideline for cervical cancer screening.
Min KJ; Lee YJ; Suh M; Yoo CW; Lim MC; Choi J; Ki M; Kim YM; Kim JW; Kim JH; Park EW; Lee HY; Lim SC; Cho CH; Hong SR; Dang JY; Kim SY; Kim Y; Lee WC; Lee JK
J Gynecol Oncol; 2015 Jul; 26(3):232-9. PubMed ID: 26197860
[TBL] [Abstract][Full Text] [Related]
37. Recommendations on screening for cervical cancer.
Dickinson J; Tsakonas E; Conner Gorber S; Lewin G; Shaw E; Singh H; Joffres M; Birtwhistle R; Tonelli M; Mai V; McLachlin M;
CMAJ; 2013 Jan; 185(1):35-45. PubMed ID: 23297138
[No Abstract] [Full Text] [Related]
38. Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up.
Jensen KE; Schmiedel S; Norrild B; Frederiksen K; Iftner T; Kjaer SK
Br J Cancer; 2013 Jan; 108(1):234-9. PubMed ID: 23169283
[TBL] [Abstract][Full Text] [Related]
39. Cervical carcinoma rates among young females in the United States.
Benard VB; Watson M; Castle PE; Saraiya M
Obstet Gynecol; 2012 Nov; 120(5):1117-23. PubMed ID: 23090530
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
